The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis

The objective of this blind, randomized controlled study was to evaluate effect of 12 months alendronate treatment on bone mineral density (BMD) and bone formation, resorption markers in postmenopausal osteoporotic women. Women with BMD values at least 2 standard deviations (SD) below BMD of adult p...

Full description

Bibliographic Details
Main Authors: S. Akı, R. G. Gulbaba, N. Eskiyurt
Format: Article
Language:English
Published: Galenos Yayinevi 2002-03-01
Series:Türk Osteoporoz Dergisi
Subjects:
Postmenopausal osteoporosis
alendronate
bone mineral density
bone formation
resorption markers.
Online Access:http://www.turkosteoporozdergisi.org/article_4172/The-Effect-Of-Alendronate-Treatment-On-Bone-Density-And-Bone-Markers-In-Postmenopausal-Osteoporosis

Internet

http://www.turkosteoporozdergisi.org/article_4172/The-Effect-Of-Alendronate-Treatment-On-Bone-Density-And-Bone-Markers-In-Postmenopausal-Osteoporosis

Similar Items